The Food and Drug Ad­min­is­tra­tion last week ap­proved the first drug to treat all forms of hepati­tis C in as lit­tle as eight weeks.

Modern Healthcare - - LATE NEWS -

The pill com­bi­na­tion from Ab­bVie joins two other Ab­bVie hepati­tis C drugs as well as one from Merck & Co. and four from Gilead Sciences on the mar­ket. That gives doc­tors and pa­tients more op­tions, and in­sur­ers more lever­age to wring dis­counts out of com­pa­nies to cover the pricey drugs. An es­ti­mated 2.7 mil­lion to 3.9 mil­lion Amer­i­cans have hepati­tis C, ac­cord­ing to the Cen­ters for Dis­ease Con­trol and Preven­tion.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.